Hickman; David T

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hickman; David T.The latest application filed is for "disaccharide synthetic lipid compounds and uses thereof".

Company Profile

0.6.10

Hickman; David T - Saint-Sulpice CH
HICKMAN; David T. - Saint-Sulpice CH
HICKMAN; David T. - Saint-SuIpice CH
Hickman; David T. - Strasbourg Cedex N/A FR
Hickman; David T. - La Tour de Treme CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Disaccharide synthetic lipid compounds and uses thereof Grant 10,143,744 - Shaw , et al. De	2018-12-04
Disaccharide Synthetic Lipid Compounds And Uses Thereof App 20170349618 - SHAW; Walter A. ; et al.	2017-12-07
Disaccharide synthetic lipid compounds and uses thereof Grant 9,518,078 - Shaw , et al. December 13, 2	2016-12-13
Disaccharide Synthetic Lipid Compounds and Uses Thereof App 20160136271 - SHAW; Walter A. ; et al.	2016-05-19
Disaccharide synthetic lipid compounds and uses thereof Grant 9,241,988 - Shaw , et al. January 26, 2	2016-01-26
Disaccharide Synthetic Lipid Compounds and Uses Thereof App 20150110854 - Shaw; Walter A ; et al.	2015-04-23
Disaccharide Synthetic Lipid Compounds And Uses Thereof App 20130273149 - SHAW; Walter A. ; et al.	2013-10-17
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers Grant 8,409,580 - Tosi , et al. April 2, 2	2013-04-02
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers App 20110064795 - Tosi; Pierre-Francois ; et al.	2011-03-17
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers Grant 7,807,171 - Tosi , et al. October 5, 2	2010-10-05
Therapeutic Vaccine Targeted Against P-glycoprotein 170 For Inhibiting Multidrug Resistance In The Treatment Of Cancers App 20080026995 - Tosi; Pierre-Francois ; et al.	2008-01-31
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers App 20060233758 - Tosi; Pierre-Francois ; et al.	2006-10-19
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers App 20050255561 - Tosi, Pierre-Francois ; et al.	2005-11-17
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers App 20050244419 - Tosi, Pierre-Francois ; et al.	2005-11-03
Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers App 20050175615 - Tosi, Pierre-Francois ; et al.	2005-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.